FMC - Madisonville Dialysis is a medicare approved dialysis facility center in Madisonville, Kentucky and it has 17 dialysis stations. It is located in Hopkins county at 1020 Waterfall Court, Madisonville, KY, 42431. You can reach out to the office of FMC - Madisonville Dialysis at (270) 825-3792. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Madisonville Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 2008. The medicare id for this facility is 182594 and it accepts patients under medicare ESRD program.
| Name | FMC - Madisonville Dialysis |
|---|---|
| Location | 1020 Waterfall Court, Madisonville, Kentucky |
| No. of Dialysis Stations | 17 |
| Medicare ID | 182594 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1020 Waterfall Court, Madisonville, Kentucky, 42431 | |
| (270) 825-3792 | |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
| NPI Number | 1588832471 |
| Organization Name | Fresenius Medical Care Madisonville |
| Doing Business As | Bio-medical Applications Of Kentucky, Inc. |
| Address | 1020 Waterfall Ct. Madisonville, Kentucky, 42431 |
| Phone Number | (270) 825-3792 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 19 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 5 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 42 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 352 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 91 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 95 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Madisonville Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 475 |
| Patients with Serumphosphor | 62 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 26 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 36 |
| Patient months included in arterial venous fistula and catheter summaries | 223 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 63 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 42 |
| Hospitalization Rate in facility | 187.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 352.7 |
| Hospitalization Rate: Lower Confidence Limit | 104.4 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Madisonville Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 27.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41 |
| Readmission Rate: Lower Confidence Limit | 16 |
News Archive
PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.
A team led by a scientist at the University of Pittsburgh School of Medicine has discovered a regulatory protein that influences where genetic material gets swapped between maternal and paternal chromosomes during the process of creating eggs and sperm. The findings, which shed light on the roots of chromosomal errors and gene diversity, appear in tomorrow's issue of Nature.
Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).
The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.
› Verified 5 days ago